Wolfson-Stofko Brett, Bennett Alex S, Elliott Luther, Curtis Ric
National Development & Research Institute, Institute for Special Populations Research, 71 W. 23rd St., 4th Fl., New York, NY 10100, United States of America; Center for Drug Use and HIV/HCV Research, Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10100, United States of America.
National Development & Research Institute, Institute for Special Populations Research, 71 W. 23rd St., 4th Fl., New York, NY 10100, United States of America; Center for Drug Use and HIV/HCV Research, Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10100, United States of America.
Int J Drug Policy. 2017 Jan;39:69-77. doi: 10.1016/j.drugpo.2016.08.014. Epub 2016 Oct 18.
Though public bathroom drug injection has been documented from the perspective of people who inject drugs, no research has explored the experiences of the business managers who oversee their business bathrooms and respond to drug use. These managers, by default, are first-responders in the event of a drug overdose and thus of intrinsic interest during the current epidemic of opioid-related overdoses in the United States. This exploratory study assists in elucidating the experiences that New York City business managers have with people who inject drugs, their paraphernalia, and their overdoses.
A survey instrument was designed to collect data on manager encounters with drug use occurring in their business bathrooms. Recruitment was guided by convenience and purposive approaches.
More than half of managers interviewed (58%, n=50/86) encountered drug use in their business bathrooms, more than a third (34%) of these managers also found syringes, and the vast majority (90%) of managers had received no overdose recognition or naloxone training. Seven managers encountered unresponsive individuals who required emergency assistance.
The results from this study underscore the need for additional research on the experiences that community stakeholders have with public injection as well as educational outreach efforts among business managers. This research also suggests that there is need for a national dialogue about potential interventions, including expanded overdose recognition and naloxone training and supervised injection facilities (SIF)/drug consumption rooms (DCR), that could reduce public injection and its associated health risks.
虽然从注射吸毒者的角度记录了公共浴室吸毒的情况,但尚未有研究探讨负责管理其经营浴室并应对吸毒问题的企业经理的经历。默认情况下,这些经理在药物过量事件中是第一响应者,因此在美国当前与阿片类药物相关的过量用药流行期间具有内在的研究价值。这项探索性研究有助于阐明纽约市企业经理与注射吸毒者、他们的用具以及过量用药情况的经历。
设计了一份调查问卷,以收集经理们在其经营浴室中遇到吸毒情况的数据。招募工作采用便利抽样和目的抽样相结合的方法。
超过一半接受采访的经理(58%,n = 50/86)在其经营浴室中遇到过吸毒情况,其中超过三分之一(34%)的经理还发现了注射器,绝大多数(90%)的经理没有接受过过量用药识别或纳洛酮培训。有7名经理遇到了需要紧急救助的无反应个体。
这项研究的结果强调需要对社区利益相关者在公共注射方面的经历进行更多研究,并对企业经理开展教育推广工作。这项研究还表明,需要进行全国性对话,讨论包括扩大过量用药识别和纳洛酮培训以及监督注射设施(SIF)/药物消费室(DCR)在内的潜在干预措施,这些措施可以减少公共注射及其相关的健康风险。